Antimicrobial, Antiviral, and Antifungal Nanocoatings (RIA)

The Antimicrobial, Antiviral, and Antifungal Nanocoatings program aims to fund collaborative research efforts to develop innovative nanocoating solutions. It targets entities capable of advancing materials science and nanotechnology to enhance public health and industrial resilience across the EU and associated countries. The program's objective is to mitigate the spread of infections and foster economic benefits by boosting R&D and creating business opportunities, particularly for SMEs.

Funding is provided for research and innovation projects focused on developing advanced nanocoatings. The program supports the entire lifecycle from basic research to pilot testing, covering a range of applications and materials, with a strong emphasis on sustainable and safe solutions.

This program provides grant funding specifically for Research and Innovation Actions (RIA). The total budget allocated for this topic is 23 million Euros, intended to support projects that align with the program's objectives.

Applicants must adhere to general conditions outlined in the Horizon Europe Work Programme General Annexes, covering admissibility, eligibility, financial capacity, and legal aspects. Specific conditions also apply to the nature of the proposals, such as including a business case and exploitation strategy.

The application process for this program was a single-stage submission, followed by an evaluation of submitted proposals by the European Commission. Successful applicants were informed of the results, with grant agreements expected to be signed following the evaluation.

The funding program operates under the comprehensive legal framework of Horizon Europe and is governed by various EU regulations and guides to ensure transparency and compliance.